FUNCTIONAL DISCREPANCIES BETWEEN TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN-ALPHA EXPLAINED BY TRIMER STABILITY AND DISTINCT RECEPTOR INTERACTIONS

被引:24
作者
SCHUCHMANN, M
HESS, S
BUFLER, P
BRAKEBUSCH, C
WALLACH, D
PORTER, A
RIETHMULLER, G
ENGELMANN, H
机构
[1] UNIV MUNICH,INST IMMUNOL,D-80336 MUNICH,GERMANY
[2] WEIZMANN INST SCI,DEPT MEMBRANE RES,IL-76100 REHOVOT,ISRAEL
[3] NATL UNIV SINGAPORE,INST MOLEC & CELLULAR BIOL,SINGAPORE 0511,SINGAPORE
关键词
TUMOR NECROSIS FACTOR; LYMPHOTOXIN; RECEPTOR;
D O I
10.1002/eji.1830250810
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor necrosis factor (TNF) and lymphotoxin alpha (LT alpha) are closely related cytokines which bind with nearly identical affinities to the same pair of cell surface receptors, p55 and p75TNFR. Therefore it is assumed that TNF and LT alpha are redundant cytokines. This study, however, demonstrates that TNF and LT alpha differ significantly with regard to their mitogenic and cytotoxic potentials. LT alpha's superior mitogenic effect could be explained by its formation of a more stable trimer. In contrast to the TNF trimer, which disintegrated under physiological conditions into biologically inactive monomers; the LT alpha trimer remained stable for several days. Accordingly, LT alpha more effectively induced fibroblast growth which demands long-term presence of the cytokine. TNF's superior cytotoxicity, which requires only short-term impact of the cytokine, could be attributed to a distinct interaction with the human p55TNFR. This was demonstrated in NIH 3T3 cells transfected with the human p55TNFR, where cytotoxicity is mediated exclusively by the transfected receptor. Although the p55TNFR had virtually identical affinities for TNF and LT alpha, as defined by Scatchard analysis, it nevertheless discriminated between binding of each cytokine and showed a 200-fold enhanced cytotoxicity mediated by TNF.
引用
收藏
页码:2183 / 2189
页数:7
相关论文
共 63 条
[1]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[2]   CHARACTERIZATION OF RECEPTORS FOR HUMAN-TUMOR NECROSIS FACTOR AND THEIR REGULATION BY GAMMA-INTERFERON [J].
AGGARWAL, BB ;
EESSALU, TE ;
HASS, PE .
NATURE, 1985, 318 (6047) :665-667
[3]   CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION [J].
BANNER, DW ;
DARCY, A ;
JANES, W ;
GENTZ, R ;
SCHOENFELD, HJ ;
BROGER, C ;
LOETSCHER, H ;
LESSLAUER, W .
CELL, 1993, 73 (03) :431-445
[4]  
BERNABEU C, 1983, J IMMUNOL, V131, P2032
[5]   UNRAVELING FUNCTION IN THE TNF LIGAND AND RECEPTOR FAMILIES [J].
BEUTLER, B ;
VANHUFFEL, C .
SCIENCE, 1994, 264 (5159) :667-668
[6]   THE BIOLOGY OF CACHECTIN/TNF - A PRIMARY MEDIATOR OF THE HOST RESPONSE [J].
BEUTLER, B ;
CERAMI, A .
ANNUAL REVIEW OF IMMUNOLOGY, 1989, 7 :625-655
[7]   DUAL ROLE OF THE P75 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR IN TNF CYTOTOXICITY [J].
BIGDA, J ;
BELETSKY, I ;
BRAKEBUSCH, C ;
VARFOLOMEEV, Y ;
ENGELMANN, H ;
BIGDA, J ;
HOLTMANN, H ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :445-460
[8]   THE MITOGENIC RESPONSE TO TUMOR-NECROSIS-FACTOR ALPHA-REQUIRES C-JUN/AP-1 [J].
BRACH, MA ;
GRUSS, HJ ;
SOTT, C ;
HERRMANN, F .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) :4284-4290
[9]   CYTOPLASMIC TRUNCATION OF THE P55 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR ABOLISHES SIGNALING, BUT NOT INDUCED SHEDDING OF THE RECEPTOR [J].
BRAKEBUSCH, C ;
NOPHAR, Y ;
KEMPER, O ;
ENGELMANN, H ;
WALLACH, D .
EMBO JOURNAL, 1992, 11 (03) :943-950
[10]  
BROUDY VC, 1987, J IMMUNOL, V138, P4298